Related Experiment Videos
Herpes simplex virus type 1 and Alzheimer's disease
1Department of Optometry and Neuroscience, University of Manchester Institute of Science and Technology, United Kingdom.
Neurobiology of Aging
|December 22, 1999
Summary
Herpes simplex virus type 1 (HSV1) is a risk factor for Alzheimer's disease (AD) in individuals carrying the APOE-epsilon4 gene. This combination of HSV1 in the central nervous system and the APOE-epsilon4 allele appears particularly damaging.
Area of Science:
- Neuroscience
- Virology
- Genetics
Background:
- Alzheimer's disease (AD) risk factors traditionally included age, Down's syndrome, and head injury.
- Herpes simplex virus type 1 (HSV1) is prevalent in the elderly brain.
- APOE-epsilon4 allele is a known risk factor for AD and herpes labialis.
Purpose of the Study:
- To investigate the role of HSV1 in Alzheimer's disease pathogenesis.
- To explore the interaction between HSV1 and the APOE genotype in the central nervous system.
- To review the implications for AD prevention and treatment.
Main Methods:
- Review of studies searching for HSV1 in human brain tissue.
- Examination of HSV1 infection in peripheral and central nervous systems.
- Analysis of APOE genotype influence on HSV1 infection, latency, and reactivation.
- Investigation of virus-lipoprotein interactions and APOE's role in repair.
Main Results:
- HSV1 presence in the central nervous system is identified as a risk factor for AD.
- The combination of HSV1 and the APOE-epsilon4 allele significantly increases AD risk.
- APOE genotype may influence HSV1 infection dynamics and the nervous system's response.
Conclusions:
- The interplay between HSV1 infection and APOE genotype is crucial in Alzheimer's disease development.
- Understanding these interactions offers potential avenues for AD prevention and therapeutic strategies.
- Targeting viral factors or APOE pathways may mitigate AD pathology.